183 related articles for article (PubMed ID: 9020150)
1. Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.
Dolan M; Horchar T; Rigatti B; Hassell JR
J Biol Chem; 1997 Feb; 272(7):4316-22. PubMed ID: 9020150
[TBL] [Abstract][Full Text] [Related]
2. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
Doege K; Chen X; Cornuet PK; Hassell J
Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
[TBL] [Abstract][Full Text] [Related]
3. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
Tapanadechopone P; Hassell JR; Rigatti B; Couchman JR
Biochem Biophys Res Commun; 1999 Nov; 265(3):680-90. PubMed ID: 10600481
[TBL] [Abstract][Full Text] [Related]
4. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1.
Kokenyesi R; Bernfield M
J Biol Chem; 1994 Apr; 269(16):12304-9. PubMed ID: 8163535
[TBL] [Abstract][Full Text] [Related]
5. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.
Kokenyesi R; Silbert JE
Biochem Biophys Res Commun; 1995 Jun; 211(1):262-7. PubMed ID: 7779094
[TBL] [Abstract][Full Text] [Related]
6. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans.
Zhang L; David G; Esko JD
J Biol Chem; 1995 Nov; 270(45):27127-35. PubMed ID: 7592967
[TBL] [Abstract][Full Text] [Related]
7. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
8. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
Noonan DM; Fulle A; Valente P; Cai S; Horigan E; Sasaki M; Yamada Y; Hassell JR
J Biol Chem; 1991 Dec; 266(34):22939-47. PubMed ID: 1744087
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.
Chen RL; Lander AD
J Biol Chem; 2001 Mar; 276(10):7507-17. PubMed ID: 11106655
[TBL] [Abstract][Full Text] [Related]
10. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.
Murdoch AD; Dodge GR; Cohen I; Tuan RS; Iozzo RV
J Biol Chem; 1992 Apr; 267(12):8544-57. PubMed ID: 1569102
[TBL] [Abstract][Full Text] [Related]
11. Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters.
Winzen U; Cole GJ; Halfter W
J Biol Chem; 2003 Aug; 278(32):30106-14. PubMed ID: 12773545
[TBL] [Abstract][Full Text] [Related]
12. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
13. Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix.
Couchman JR; Kapoor R; Sthanam M; Wu RR
J Biol Chem; 1996 Apr; 271(16):9595-602. PubMed ID: 8621634
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP regulates basement membrane heparan sulfate proteoglycan, perlecan, metabolism in rat glomerular epithelial cells.
Ko CW; Bhandari B; Yee J; Terhune WC; Maldonado R; Kasinath BS
Mol Cell Biochem; 1996 Sep; 162(1):65-73. PubMed ID: 8905627
[TBL] [Abstract][Full Text] [Related]
17. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I.
French MM; Gomes RR; Timpl R; Höök M; Czymmek K; Farach-Carson MC; Carson DD
J Bone Miner Res; 2002 Jan; 17(1):48-55. PubMed ID: 11771669
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycans of basement membranes.
Timpl R
EXS; 1994; 70():123-44. PubMed ID: 8298244
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides.
Costell M; Mann K; Yamada Y; Timpl R
Eur J Biochem; 1997 Jan; 243(1-2):115-21. PubMed ID: 9030729
[TBL] [Abstract][Full Text] [Related]
20. Basement membrane proteoglycans are of epithelial origin in rodent skin.
Yamane Y; Yaoita H; Couchman JR
J Invest Dermatol; 1996 Mar; 106(3):531-7. PubMed ID: 8648189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
